#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neurofibroma Thrombotic microangiopathy Follicular lymphoma stage I Pulmonary hypertension Mixed-type liposarcoma Stress cardiomyopathy Glycogen storage disease type II Wiskott-Aldrich syndrome Bile acid synthesis disorder Granulomatosis with polyangiitis Cataract Autoimmune myositis Exudative retinopathy Complex regional pain syndrome Plasma cell myeloma recurrent More trials…

    Learn about Rare Diseases

    Sarcoma – Basic Information Hairy cell leukaemia recurrent – Life with Disease Breast angiosarcoma Bronchopulmonary dysplasia – Treatment Pulmonary sarcoidosis – Basic Information Hyperoxaluria – Trials in Disease Alport’s syndrome – Life with Disease Pleural mesothelioma malignant – Treatment Splenic marginal zone lymphoma – Diagnostics Gaucher’s disease type I More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mebendazole Adenosine Ofloxacin Hydrochloride INSULIN DEGLUDEC Nelivaptan Vitamin A Bp Quinine Dihydrochloride Anhydrous Azithromycin ALFENTANIL HYDROCHLORIDE Piperacillin Human Apotransferrin INDAPAMIDE HEMIHYDRATE Placebo Lolium Perenne Metamizole Magnesium Lufepirsen Imifoplatin For-6219 Nnc0194-0499 Dermatophagoides Farinae More therapies…

    Learn about Your Condition

    Premature rupture of membranes Toxic nodular goitre Pneumonia chlamydial Hyperhidrosis Erythema multiforme Cutaneous sarcoidosis Normal pressure hydrocephalus Mucosal inflammation Skin candida Dermatitis atopic Tissue anoxia COVID-19 Indolent systemic mastocytosis Deep vein thrombosis Pruritus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Renal cell carcinoma

  • Testing Cabozantinib Dose Skipping Schedule Compared to Dose Reduction in Patients with Kidney Cancer Taking Cabozantinib Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma
    Investigated Drugs:
    • Cabozantinib
    The Netherlands

  • A study to evaluate the safety and effectiveness of PTT-4256 and nivolumab in patients with solid tumors.

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Nivolumab
    France Spain

  • Study of Pembrolizumab and Enfortumab Vedotin for Patients with Collecting Duct and Renal Medullary Carcinoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-renal cell carcinoma of kidney
    • Renal cell carcinoma
    Investigated Drugs:
    • Pembrolizumab
    Italy

  • Study on the Safety and Effectiveness of AL8326 for Patients with Small Cell Lung Cancer Needing Second-Line Treatment

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    • Renal cell carcinoma
    • Small cell lung cancer
    Investigated Drugs:
    • Al8326
    Italy Spain

  • Study on Nivolumab Dose Optimization for Patients with Melanoma or Renal Cell Carcinoma Showing Complete, Partial, or Stable Response

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    • Renal cell carcinoma
    Investigated Drugs:
    • Nivolumab
    The Netherlands

  • Study of Axitinib and Avelumab for Patients with Localized Renal Cell Carcinoma at Moderate to High Risk of Recurrence

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma
    Investigated Drugs:
    • Avelumab
    • Axitinib
    The Netherlands
Previous Page
1 2 3 4 5 … 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!